Showing results (291-300 of 304) with videos related to
Sort By:
Pageof 31
The Lancet. Neurology|December 22, 2022
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trialMelinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard, et al.Cell Genomics|June 30, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitisAndrew C Brown, Carla J Cohen, Olga Mielczarek, et al.Cancer|August 2, 2018
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinomaRandall Brand, Erkut Borazanci, Virginia Speare, et al.Journal of Clinical and Translational Science|September 22, 2025
Building a collaborative ecosystem across the IDeA-CTR networks in response to a public health emergencyA Jerrod Anzalone, Sharon Patrick, Amber Abel, et al.JACC. Cardiooncology|November 16, 2023
Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415)Moriah P Bellissimo, Justin M Canada, Jennifer H Jordan, et al.Radiation Research|December 4, 2003
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003C Norman Coleman, Helen B Stone, George A Alexander, et al.Radiation Research|November 19, 2004
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003Helen B Stone, John E Moulder, C Norman Coleman, et al.Carcinogenesis|June 25, 2015
The effect of environmental chemicals on the tumor microenvironmentStephanie C Casey, Monica Vaccari, Fahd Al-Mulla, et al.Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.Pageof 31